Literature DB >> 8923153

Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study.

E Bonora1, G Targher, M B Zenere, F Saggiani, V Cacciatori, F Tosi, D Travia, M G Zenti, P Branzi, L Santi, M Muggeo.   

Abstract

OBJECTIVE: To examine the relationships of serum uric acid concentration with several risk factors of cardiovascular diseases (CVD).
SUBJECTS: 957 men 18 y old participating in the Verona Young Men Atherosclerosis Risk Factors Study, a cross-sectional population-based study. MEASUREMENTS: Body mass index (BMI), waist/hip ratio (WHR), serum uric acid, serum lipids, blood pressure, fasting insulin and behavioural variables.
RESULTS: Serum uric acid concentration showed positive associations with BMI (r = 0.24; P < 0.0001), WHR (r = 0.19; P < 0.0001) and serum triglyceride levels (r = 0.19; P < 0.0001); it was also significantly correlated to systolic (r = 0.08; P < 0.01) and diastolic (r = 0.11; P < 0.001) blood pressure, fasting insulin (r = 0.11; P < 0.001), total (r = 0.12; P < 0.001) and LDL cholesterol (r = 0.10; P < 0.01) plasma concentrations. Life-style characteristics, such as smoking and physical activity did not show any significant association, while daily alcohol intake was positively associated with uric acid concentration (r = 0.09; P < 0.01). While the adjustment for fasting insulin did not substantially change these results, the magnitude of the correlations between uric acid and CVD risk factors markedly decreased when allowance was made for BMI and WHR. Only triglycerides maintained an independent correlation with uric acid levels (r = 0.17; P < 0.0001). In multivariate regression analysis, serum triglycerides, BMI and WHR (at borderline significance) were independent positive predictors of uric acid (R2 of the model 0.122, P < 0.001), while fasting insulin concentration did not give any independent contribution to explain the variability uric acid levels.
CONCLUSIONS: These data indicate that, already in young, essentially health subjects, hyperuricaemia associates with several components of the so-called insulin resistance syndrome, thus suggesting that increased levels of uric acid might be another member of this syndrome. In addition, these data suggest that obesity and central body fat distribution, rather than hyperinsulinaemia/insulin resistance, play a major role in linking hyperuricaemia with CVD risk factors clustering in the insulin resistance syndrome. Nevertheless, hypertrigliceridemia is related to hyperuricemia independently of obesity and central body fat distribution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923153

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  56 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Authors:  Wolfgang Rathmann; Burkhard Haastert; Andrea Icks; Guido Giani; Jeffrey M Roseman
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 8.082

4.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

5.  Positive association between serum uric acid and bone mineral density in Chinese type 2 diabetes mellitus stratified by gender and BMI.

Authors:  Mingxin Xu; Junlei Su; Jie Hao; Ni Zhong; Zhiyin Zhang; Ran Cui; Feng Li; Chunjun Sheng; Ge Zhang; Hui Sheng; Shen Qu
Journal:  J Bone Miner Metab       Date:  2017-11-09       Impact factor: 2.626

6.  Influence of different concentrations of uric acid on oxidative stress in steatosis hepatocytes.

Authors:  Shi Cheng; Yan Yang; Yong Zhou; Wei Xiang; Hua Yao; Ling Ma
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

7.  The prevalence of metabolic syndrome in patients with gout: a multicenter study.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Kyung Mook Choi; Sei Hyun Baik; Seung-hie Chung; Chae-Gi Kim; Jung-Yoon Choe; Sung Won Lee; Won Tae Chung; Gwan Gyu Song
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

8.  Hyperuricaemia and the metabolic syndrome in type 2 DM.

Authors:  Anthonia O Ogbera; Alfred O Azenabor
Journal:  Diabetol Metab Syndr       Date:  2010-04-20       Impact factor: 3.320

9.  The associations of serum uric acid level and hyperuricemia with knee osteoarthritis.

Authors:  Xiang Ding; Chao Zeng; Jie Wei; Hui Li; Tuo Yang; Yi Zhang; Yi-Lin Xiong; Shu-Guang Gao; Yu-Sheng Li; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2016-01-07       Impact factor: 2.631

10.  Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women.

Authors:  T Montalcini; G Gorgone; C Gazzaruso; G Sesti; F Perticone; A Pujia
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.